MSB 0.66% $1.53 mesoblast limited

Gilead vs Mesoblast, page-33

  1. 1,743 Posts.
    lightbulb Created with Sketch. 187
    “ If their drug works,and patients walk out of hospital with no further respiratory complications - then suddenly there is no one in further need of critical care and thus our stem cells. “

    1. We don’t have trial results yet, so we can’t tell if their drug works, or if these patients were going to recover naturally anyway.

    2. Patients can rapidly deteriorate, and it may not be viable to treat many before developing a need for critical care.

    3. Even if it does work, it can do nothing for helping to repair any damage to the lungs, so it is premature to assume recovered patients will have no further need of stem cells.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.53
Change
0.010(0.66%)
Mkt cap ! $1.712B
Open High Low Value Volume
$1.50 $1.54 $1.48 $5.605M 3.713M

Buyers (Bids)

No. Vol. Price($)
5 55197 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.53 29782 3
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.